Beovu 120mg/ml, Injektionslösung in Fertigspritze
7680672440019
CH-67244
Injektionslösung in Fertigspritze
Associated product:
BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung in Fertigspritze
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
brolucizumabum
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
natrii citras anhydricus
|
- | Substance | HNIDK |
|
polysorbatum 80
|
0.2 MG | Substance | HBESI |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.82 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 726.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2020
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67244
- Drug name
- Beovu, Injektionslösung in Fertigspritze
- Galenic form
- INLFS
- ATC Code
- S01LA06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 16/01/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 11.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
- Description (DE)
- BEOVU Inj Lös 6 mg/0.05ml Fertigspr 0.165 ml
- Market launch
- 16/01/2020
- Narcotic (BTM)
- No